Unlocking Precision in Cell Therapy

Powering Intelligent Manufacturing for the Next Generation of Cell Therapies

AiCella combines AI and advanced Machine Learning to accelerate CGT development and manufacturing processes, ensuring smarter data driven decisions and reliable outcomes

Schedule a Consultation Learn More

Female Research Scientist with Bioengineer Working on a Personal Computer with Screen Showing Virus Analysis Software User Interface. Scientists Developing Vaccine, Drugs and Antibiotics in Laboratory

Optimize Your Cell Therapy Process with Rigorous, Actionable AI Insights

AI / ML Driven Insights

AiCella Insights platform provides comprehensive and customizable AutoML and process design toolkit with AI agents that incorporates analysis of process data to determine critical parameters for cell therapy development.

Realtime Monitoring

Utilize dynamic and intuitive visualizations to monitor and interpret critical data in real time, enhancing decision making for development and manufacturing.

Customizable Workflow Automation

Adapt our platform to your team’s unique process development needs with fully customizable workflows, analyses, and visualizations. Automate key processes to improve efficiency, reduce manual error, and enable more scalable workflow.

Explainable and Statistically Rigorous

AiCella makes AI accessible to non experts by delivering explainable insights supported by rigorous statistical analysis. Our LLM agents also provide reliable and verifiable responses that you can trust.

Connecting Clinical Responses

Establish connections between patient clinical responses and key process parameters, enabling a deeper understanding of how treatments affect patients.

Security and Compliance

Our platform is SOC 2 compliant and built with strong security and confidentiality controls to protect your data. With secure data transmission, controlled access, and responsible data management, we help teams operate confidently in regulated settings.

Learn More About Our Platform

Proven Improvements By the Numbers

100%

of clients report accelerated decision making through to our platform

50+

clinical studies supported with our PLATFORM

72%

process optimization efficiency achieved through our platform On Average

7 weeks

reduction in average time to market for cell therapy products

100%

commitment to DATA SECURITY

Our Leadership

Geoffrey Stephens, PhD, MBA

Founder & CEO

Michael Howell, PhD

Cofounder & CSO (ZuraBio)

Mark Hazeltine, MBA

Cliona Rooney, PhD

Professor, Baylor College of MediciNE

Ron Rocca

President & CEO (Mindera)

"What set AiCella apart was not just their technical execution, but their collaborative mindset, and subject matter expertise. Their transparency, responsiveness, and integrity made them a true strategic partner. "

Raluca Dumitru, Senior Director, Charles River Labs

Get In Touch With Us

Reach out to us to learn how our platform can enhance your cell therapy processes.

Email: info@aicella.com

Address: 9276 Scranton Rd. Suite 500, San Diego, California, 92121

Accelerate Your Cell Therapy Development with AiCella

Get clear insights into your process and optimize for better patient outcomes. Start making data driven decisions today.